by Maison P, Zureik M, Hivert V, Kjaer J, Khonsari RH, Trifirõ G and Ratignier-Carbonneil C (2022). Front. Pharmacol. 13:969091. doi: 10.3389/fphar.2022.969091
Due to a production error, in the article citation, the name of author Roman Hossein Khonsari was erroneously inserted as “Hossein Khonsari R” instead of “Khonsari RH”; additionally, in the copyright statement, it was mistakenly written as “Hossein Khonsari”, instead of “Khonsari”.
The publisher apologizes for this mistake.
The original version of this article has been updated.
Keywords: real-world data (RWD), real-world evidence (RWE), big data, pharmacoepidemiology, pharmacovigilance, regulatory agencies, patient engagement, regulatory science
Citation: Frontiers Production Office (2025) Erratum: Real-world evidence (RWE): a challenge for regulatory agencies discussion of the RWE conference with the network of the European medicine agencies, patients, and experts. Front. Pharmacol. 16:1601645. doi: 10.3389/fphar.2025.1601645
Received: 28 March 2025; Accepted: 28 March 2025;
Published: 07 April 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn